DJIA 17,109.86 38.64 0.23%
NASDAQ 4,513.11 7.26 0.16%
S&P 500 1,981.51 3.71 0.19%
market minute promo

CEMPRA INC (NASDAQ: CEMP)

10.84 0.04 (0.37%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CEMP $10.84 0.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.82
Previous Close $10.80
Daily Range $10.70 - $11.00
52-Week Range $8.10 - $15.39
Market Cap $360.4M
P/E Ratio -5.48
Dividend (Yield) $0.00 (0.0%)
Volume 96,556
Average Daily Volume 159,969
Current FY EPS -$2.11

Sector

Industry

CEMPRA INC (CEMP) Description

Cempra Inc is a clinical-stage pharmaceutical company which is developing antibiotics to meet critical unmet medical needs in the treatment of bacterial infectious diseases particularly respiratory tract infections and skin and skin structure infections. Website: http://www.cempra.com/

News & Commentary Rss Feed

Health Care Plunge: 4 Stocks Falling Hard

Cempra (CEMP) Jumps: Stock Up 8.9% in Session - Tale of the Tape

Morning Market Losers

3 Unusual-Volume Biotech Stocks in Breakout Territory

Sector Update: Health Care Stocks Lagging Broader Market; Cempra Wraps Trial Enrollment for Pneumoni

Sector Update: Health Care Stocks Lagging Broader Market; Cempra Wraps Trial Enrollment for Pneumonia Drug

Sector Update: Health Care

Cempra Completes Enrollment of Solitaire-Oral Phase 3 Trial

Marijuana & Antidotes: GSK & CEMP Nursing Pulmonary Diseases

Cempra, Inc. Receives $10M Milestone Payment From Toyama Chemical Co. Triggered By Solithromycin's C

Cempra, Inc. Receives $10M Milestone Payment From Toyama Chemical Co. Triggered By Solithromycin's Clinical Development Progress In Japan

Steve Brozak: Big-Picture Biotech Stocks Rule The Future

Cempra's (CEMP) CEO Prabha Fernandes on Q2 2014 Results - Earnings Call Transcript

See More CEMP News...